Phase III study of ST-HT for common cold
Phase 3
Completed
- Conditions
- Common cold
- Registration Number
- JPRN-jRCT1080224940
- Lead Sponsor
- SSP Co., Ltd.
- Brief Summary
The drug ameliorated a variety of symptoms in patients with common cold and was well tolerated in terms of safety and was considered safe for over-the-counter use.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 148
Inclusion Criteria
1. Common cold patient diagnosed by the invetigator
2. age: 15 years old and above at the time of giving consent
3. Patient who gives written consent
etc.
Exclusion Criteria
1. Patinet who was diagnosed as influenza by the investigator
2. Patient with underlying chronic upper airway disease or lowe ariway disease
3. Patine with seasonal nasal allergy during taking the study medication
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy<br>Overall improvement
- Secondary Outcome Measures
Name Time Method safety<br>efficacy<br>Score of improvement by symptoms<br>Overall safety